A Look At Analog Devices (ADI) Valuation As Industrial Growth And Analyst Upgrades Draw Attention

أنالوغ ديفايسز إنك -0.35%

Analog Devices, Inc.

ADI

350.14

-0.35%

Analog Devices (ADI) is back in focus after its industrial division reported 38% year over year growth and strong demand for AI chip testing equipment, alongside positive analyst commentary on the stock.

Recent enthusiasm around the industrial growth story and bullish analyst commentary has come alongside a 90 day share price return of 16.29%, contributing to a 1 year total shareholder return of 96.35%. This indicates strong momentum following a period of shorter term volatility.

If AI hardware and testing demand has your attention, it can be useful to see which other names are benefiting from similar themes using our stock screener for 36 AI infrastructure stocks

With Analog Devices up 96.35% over the past year and trading at US$318.34, while analyst targets sit higher around US$386.59, the key question is whether there is still a buying opportunity or if markets are already pricing in future growth.

Most Popular Narrative: 16.1% Undervalued

At a last close of $318.34 versus a narrative fair value of $379.64, the most followed view sees upside already embedded in detailed growth and margin assumptions.

Disciplined capital allocation, with a focus on R&D, strategic partnerships (such as with NVIDIA and Teradyne), and shareholder returns, positions ADI to drive sustainable EPS growth and further enhance financial resilience as secular growth drivers unfold across its diversified end markets.

Curious what has to happen for that higher value to stack up? Revenue, margins, and earnings all shift meaningfully in this narrative. The exact mix might surprise you.

Result: Fair Value of $379.64 (UNDERVALUED)

However, you still need to weigh risks such as rising lower cost competition and potential supply chain or trade disruptions that could quickly challenge this upbeat setup.

Another Way To Look At The Valuation

The SWS DCF model presents a more conservative view for Analog Devices, with an estimated future cash flow value of $185.40 compared with the current $318.34 share price. On this basis, the shares appear expensive, which raises the question of which set of assumptions is more reliable.

ADI Discounted Cash Flow as at Apr 2026
ADI Discounted Cash Flow as at Apr 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Analog Devices for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 59 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment clearly split between upside potential and valuation questions, now is a good time to review the key data and form your own view by using the full breakdown of 3 key rewards and 1 important warning sign

Looking for more investment ideas?

If you stop with just one company, you might miss opportunities that fit your style even better, so put a few fresh ideas on your radar now.

  • Spot potential mispricing quickly by checking out companies in the 59 high quality undervalued stocks and see which ones deserve a closer look.
  • Strengthen your income stream by reviewing stocks in the 13 dividend fortresses that focus on higher yields.
  • Limit unpleasant surprises by focusing on companies highlighted in the 68 resilient stocks with low risk scores that prioritise resilience.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.